CD34+ CD90+ cells and late hematopoietic reconstitution after autologous peripheral blood stem cell transplantation

Leukemia and Lymphoma

Volumn 45, Issue 4, 2004, Pages 661-668

  Shimazaki, Chihiro ^a   Sumikuma, Toshiya ^a   Inaba, Tohru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Autologous peripheral blood stem cell transplantation; CD34+ CD90+ cells; CD34+ cells; Late hematopoietic reconstitution

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CYCLOPHOSPHAMIDE; FIBRINOGEN RECEPTOR; HLA DR ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THY 1 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW CELL; BONE MARROW PURGING; CELL DIFFERENTIATION; ERYTHROID CELL; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; LEUKAPHERESIS; LONG TERM CARE; MEGAKARYOCYTE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL MOBILIZATION;

ANTIGENS, CD34; ANTIGENS, THY-1; CELL COUNT; GRAFT SURVIVAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; KINETICS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 1342344864     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000140997     Document Type: Review

References (78)

1. Kessinger, A. and Armitage, J.O. (1991) "The evolving role of autologous peripheral blood stem cell transplantation following high-dose therapy for malignancies", Blood, 77, 211-213.
2. Shimazaki, C., Oku, N., Ashihara, E., Okawa, K., Goto, H., Inaba, T., et al. (1992) "Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicine followed by recombinant human granulocyte colony-stimulating factor", Bone Marrow Transplantation, 10, 341-346.
3. + hematopoietic stem cells", Blood, 83, 3758-3779.
4. Siena, S., Bregni, M., Brando, B., Belli, N., Ravagnani, F., Gandola, L., et al. (1991) "Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients", Blood, 77, 400-409.
5. Bensinger, W.L., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., et al. (1994) "Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation", British Journal of Haematology, 87, 825-831.
6. Weaver, C.H., Hazelton, B., Birch, R., Palmer, P., Allen, C., Schwartzberg, L., et al. (1995) "An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy", Blood, 86, 3961-3969.
7. + cells in early and late trilineage haematopoietic engraftment after autologous blood stem cell transplantation", British Journal of Haematology, 103, 568-581.
8. +CD33 cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients", Journal of Clinical Oncology, 16, 2093-2104.
9. + cells and rapid hematopoietic recovery after peripheral blood stem cell transplantation", Journal of Clinical Oncology, 13, 1922-1932.
10. + cells best predict platelet recovery after autologous peripheral blood stem cell transplantation", Bone Marrow Transplantation, 21, 1217-1222.
11. + cell dose", Bone Marrow Transplantation, 23, 1237-1243.
12. Menendez, P., Caballero, M.D., Prosper, F., Del Canizo, M.C., Perez-Simon, J.A., Mateos, M.V., et al. (2002) "Transplantation of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization", Transfusion, 42, 1159-1172.
13. Haas, R., Witt, B., Mohle, R., Goldschmidt, H., Hohaus, S., Fruehaus, S., et al. (1995) "Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support", Blood, 85, 3754-3761.
14. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation", Bone Marrow Transplantation, 19, 303-310.
15. Amigo, M.L., del Canizo, M.C., Caballero, M.D., Vazquerz, L., Corral, M., Vidriales, B., et al. (1999) "Factors that influence long-term hematopoietic function following autologous stem cell transplantation", Bone Marrow Transplantation, 24, 289-293.
16. + cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation", Bone Marrow Transplantation, 24, 1279-1283.
17. Duggan, P.R., Guo, D., Luider, J., Auer, I., Klassen, J., Chaudhry, A., et al. (2000) "Predictive factors for long-term engraftment of autologous blood stem cells", Bone Marrow Transplantation, 26, 1299-1304.
18. + cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation", British Journal of Haematology, 117, 238-244.
19. To, L.B., Roberts, M.M., Haylock, D.N., Dyson, P.G., Branford, A.L., Thorp, D., et al. (1992) "Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplant", Bone Marrow Transplantation", 9, 277-284.
20. Bensinger, W.I., Singer, J., Appelbaum, F., Lilleby, K., Longin, K., Rowley, S., et al. (1993) "Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor", Blood, 81, 3158-3163.
21. Beyer, J., Schwella, J., Zingsem, J., Strohscheer, I., Oettle, H., Serke, S., et al. (1995) "Hematopoietic rescue after high dose chemotherapy using autologous peripheral blood progenitor cells or bone marrow. A randomized comparison", Journal of Clinical Oncology, 13, 1328-1335.
22. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., et al. (1996) "Randomized trial of filgrastim mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients", Lancet, 347, 353-357.
23. Benboubker, L., Cartron, G., Roingeard, F., Delain, M., Degenne, M., Linassier, C., et al. (2003) "Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow", Experimental Hematology, 31, 89-97.
24. To, L., Haylock, D.N., Dowse, P.J., Simmons, P.J., Trimboli, S., Ashman, L.K., et al. (1994) "A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells", Blood, 84, 2930-2939.
25. Tjonnfjord, G.E., Steen, R., Evensen, S., Thorsby, E. and Egeland, T. (1994) "Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor", Blood, 84, 2795-2801.
26. Inaba, T., Shimazaki, C., Hirata, T., Ashihara, E., Okawa, K., Oku, N., et al. (1994) "Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection", Bone Marrow Transplantation, 13, 527-532.
27. Bolwell, B., Goormastics, M., Anderson, S., Koo, A., Wise, K., Overmoyer, B., et al. (1998) "Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation", Bone Marrow Transplantation, 22, 547-551.
28. + hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation", Haematologica, 84, 517-524.
29. Tricot, G., Jagannath, S., Vesole, D., Nelson, J., Tindle, S., Miller, L., et al. (1995) "Peripheral blood stem cell transplants for multiple myeloma: Identification of favourable variables for rapid engraftment in 225 patients", Blood, 85, 588-596.
30. Hirao, A., Kawano, Y., Takaue, Y., Suzue, T., Abe, T., Sato, J., et al. (1994) "Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system", Experimental Hematology, 22, 521-526.
31. Brendel, C. and Neubauer, A. (2000) "Characteristics and analysis of normal and leukemic stem cells: Current concepts and future direction", Leukemia, 14, 1711-1717.
32. Lansdorp, P.M., Sutherland, H.J. and Eaves, C.J. (1990) "Selective expression of CD45 isoforms on functional subpopulations of CD34+ hematopoietic cells from human bone marrow", Journal of Experimental Medicine, 172, 363-366.
33. Papayannopoulou, T., Brice, M., Broady, V.C. and Zsebo, K.M. (1991) "Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile", Blood, 78, 1403-1412.
34. Drach, D., Zhao, S., Crach, J., Mahadevia, R., Gattringer, C., Huber, H., et al. (1992) "Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype", Blood, 80, 2729-2734.
35. +CD38 progenitor cells", Blood, 77, 1218-1227.
36. +)", Experimental Hematology, 19, 680-682.
37. Andrews, R.G., Singer, J.W. and Bernstein, I.D. (1989) "Precursors of colony-forming cells in human can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties", Journal of Experimental Medicine, 169, 1721-1731.
38. Pierelli, L., Teofili, L., Menichella, G., Rumi, C., Paoloni, A., Lovino, S., et al. (1994) "Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells", British Journal of Haematology, 84, 24-30.
39. Brandt, J., Baird, N., Lu, L., Srour, E. and Hoffman, R. (1988) "Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro", Journal of Clinical Investigation, 82, 1017-1027.
40. Siena, S., Bregni, M., Brando, B., Ravagnani, F., Bonadonna, G. and Gianni, A.M. (1989) "Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor", Blood, 74, 1905-1914.
41. Baum, C.M., Weissman, I.L., Tsukamoto, A.S., Buckle, A.M. and Peault, B. (1992) "Isolation of a candidate human hematopoietic stem cell population", Proceedings of National Academy of Science USA, 89, 2804-2808.
42. Miraglia, S., Godfrey, W., Yin, A.H., Atkins, K., Warnke, R., Holden, J.T., et al. (1997) "A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning", Blood, 90, 5013-5021.
43. Ziegler, B.L., Vertieri, M., Porada, G.A., De Maria, R., Muller, R., Masella, B., et al. (1999) "KDR receptor: A key marker defining hematopoietic stem cells", Science, 285, 1553-1558.
44. Seiffert, N., Cant, C., Chen, Z., Rappold, I., Brugger, W., Kanz, L., et al. (1999) "Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47", Blood, 94, 3633-3643.
45. Yin, A.H., Miraglia, S., Zanjani, E.D., Almeida-Porada, G., Ogawa, M., Leary, A., et al. (1997) "AC133, a novel marker for human hematopoietic stem and progenitor cells", Blood, 90, 5002-5012.
46. DeWynter, E.A., Buck, D., Hart, C., Heywood, R., Coutinho, L.H., Clayton, A., et al. (1998) "CD34+ AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cells progenitors", Stem Cells, 16, 387-396.
47. Peichev, M., Naiyer, A.J., Pereira, D., Zhu, Z., Lane, W.J., Williams, M., et al. (2000) "Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors", Blood, 95, 952-958.
48. Williams, A.F. (1985) "Immunoglobulin-related domains for cell surface recognition", Nature, 314, 579-580.
49. Gunter, K.C., Malek, T.R. and Shevach, E.M. (1984) "T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/Leu-4", Journal of Experimental Medicine, 159, 716-730.
50. 2+ independent mechanism", Journal of Experimental Medicine, 173, 515-518.
51. Kroczek, R.A., Gunter, K.C., Seligmann, B. and Shevak, E.M. (1986) "Induction of T-cell activation by monoclonal antiThy-1 antibodies", Journal of Immunology, 136, 4379-4384.
52. fyn protein tyrosine kinase in T cells", Journal of Biological Chemistry, 267, 12317-12322.
53. Craig, W., Kay, R., Cutler, R.L. and Landsorp, M. (1993) "Expression of Thy-1 on human hematopoietic progenitor cells", Journal of Experimental Medicine, 177, 1331-1342.
54. Mayani, H. and Lansdorp, P.M. (1994) "Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood", Blood, 83, 2410-2417.
55. - subpopulation from mobilized peripheral blood", Blood, 85, 368-378.
56. + hematopoietic progenitor cells", Blood, 85, 1936-1943.
57. + cells", Blood, 87, 949-955.
58. Ashihara, E., Shimazaki, C., Okano, A., Hatsuse, M., Inaba, T. and Nakagawa, M. (2000) "Feasibility and efficacy of high-dose etoposide followed by low-dose granulocyte colony-stimulating factor as a mobilization regimen in patients with non-Hodgkin's lymphoma", Haematologica, 85, 1112-1114.
59. + stem cell content of peripheral blood collections", Experimental Hematology, 23, 1619-1627.
60. Haas, R., Mohle, R., Murea, S., Goldschmidt, H., Pforsich, M., Witt, B., et al. (1994) "Characterization of peripheral blood progenitor cells mobilized by cytotoxic chemotherapy and recombinant human granulocyte colony stimulating factor", Journal of Hematotherapy, 3, 323-330.
61. Gazzit, Y., Tian, E., Barlogie, B., Reading, C., Vesole, D.H., Jagannath, S., et al. (1996) "Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor", Blood, 87, 805-811.
62. Menendez, P., Prosper, F., Bueno, C., Arbona, C., San Miguel, J.F., Garcia-Conde, J., et al. (2001) "Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide", Leukemia, 15, 430-439.
63. + absolute counts and subsets", Blood Marrow Transplantation, 30, 851-860.
64. Anderlini, P., Korblin, M., Dale, D., Gratwohl, A., Schmitz, N., Stroncek, D., et al. (1997) "Allogeneic blood stem cell transplantation: Consideration for donors", Blood, 90, 903-908.
65. dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors", Transfusion, 37, 406-410.
66. - stem cells in fatal sheep", Experimental Hematology, 24, 795-806.
67. Tricot, G., Gazitt, Y., Leemhuis, T., Jagannath, S., Desikan, K.R., Siegel, D., et al. (1998) "Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitors cells to support high dose therapy in multiple myeloma", Blood, 91, 4489-4495.
68. + hematopoietic stem cells in patients with metastatic breast cancer", Biology and Blood and Marrow Transplantation, 6, 262-271.
69. + hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution", Experimental Hematology, 28, 858-870.
70. Perey, L., Peters, R., Pampallona, S., Schneider, P., Gross, N. and Leyvraz, S. (1998) "Extensive phenotypic analysis of CD34 subsets in successive collections of mobilized peripheral blood progenitors", British Journal of Haematology, 103, 618-629.
71. + cell dose", Bone Marrow Transplantations, 25, 435-440.
72. + cell dose, but steady state levels do not correlate with bone marrow reserve", British Journal of Haematology, 114, 937-943.
73. Lanza, F., Campioni, D., Moretti, S., Dominici, M., Punturieri, M., Focarile, E., et al. (2001) "CD34+ cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous and peripheral blood stem cell transplantation", Experimental Hematology, 29, 1484-1493.
74. Koehl, U., Zimmermann, S., Esser, R., Sorensen, J., Gruttner, H.P., Duchscherer, M., et al. (2002) "Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia", Bone Marrow Transplantation, 29, 927-930.
75. Gordon, P.R., Leimig, T., Babarin-Dorner, A., Houston, J., Holladay, M., Muller, I., et al. (2003) "Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells", Bone Marrow Transplantation, 31, 17-22.
76. Gallacher, L., Murdoch, B., Wu, D.M., Karanu, F.N., Keeney, M. and Bhatia, M. (2000) "Isolation and characterization of human CD34-Lin- and CD34+Lin-hematopoietic stem cells using cell surface markers AC133 and CD7", Blood, 95, 2813-2820.
77. - with engraftment post-PBSC transplantation", British Journal of Haematology, 104, 643-644.
78. - cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue", Bone Marrow Transplantation, 22, 469-475.